Damaschin, C., Goergen, H., Kreissl, S., Plütschow, A., Breywisch, F., Mathas, S., . . . Eichenauer, D. A. (2022). Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma. Leukemia, 36(2), 580. https://doi.org/10.1038/s41375-021-01386-z
Chicago-referens (17:e uppl.)Damaschin, Carla, et al. "Brentuximab Vedotin-containing Escalated BEACOPP Variants for Newly Diagnosed Advanced-stage Classical Hodgkin Lymphoma." Leukemia 36, no. 2 (2022): 580. https://doi.org/10.1038/s41375-021-01386-z.
MLA-referens (9:e uppl.)Damaschin, Carla, et al. "Brentuximab Vedotin-containing Escalated BEACOPP Variants for Newly Diagnosed Advanced-stage Classical Hodgkin Lymphoma." Leukemia, vol. 36, no. 2, 2022, p. 580, https://doi.org/10.1038/s41375-021-01386-z.
